*Development of the recombinant vaccine against poultry coccidiosis.
Public support
Provider
Ministry of Industry and Trade
Programme
IMPULSE
Call for proposals
IMPULS 1 (SMPO200400003)
Main participants
—
Contest type
VS - Public tender
Contract ID
—
Alternative language
Project name in Czech
*Vývoj rekombinantní vakcíny proti kokcidióze drůbeže.
Annotation in Czech
*Vývoj rekombinantní vakcíny nebo terapeutické proteinové substance proti kokcidióze drůbeže. Bude využita technika "postgenomové doby", "DNA microarray" pro analýzu geneové exprese v unikátních oslabených kmenech Eimeria tenella a pro identifikaci genů,které mohou být díky zvláštní regulaci v průběhu adheze zodpovědné za virulenci a patogenitu parazitů. Budou klonovány kandidátní geny a bude ověřena jejich schopnost indukovat imunitní odpověď nebo změny v životním cyklu parazitů.
Scientific branches
R&D category
PV - Industrial research
CEP classification - main branch
GJ - Diseases and animal vermin, veterinary medicine
CEP - secondary branch
EI - Biotechnology and bionics
CEP - another secondary branch
—
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40301 - Veterinary science<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
Acceptable
Solution timeline
Realization period - beginning
Jan 1, 2004
Realization period - end
Jan 1, 2006
Project status
U - Finished project
Latest support payment
—
Data delivery to CEP
Confidentiality
C - Předmět řešení projektu podléhá obchodnímu tajemství (§ 504 Občanského zákoníku), ale název projektu, cíle projektu a u ukončeného nebo zastaveného projektu zhodnocení výsledku řešení projektu (údaje P03, P04, P15, P19, P29, PN8) dodané do CEP, jsou upraveny tak, aby byly zveřejnitelné.
Data delivery code
CEP07-MPO-FI-U/01:1
Data delivery date
Jun 21, 2007
Finance
Total approved costs
27,164 thou. CZK
Public financial support
12,813 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
14,351 thou. CZK